Abstract
The current methods, such as Binomial Probability Distribution or T-test, to calculate the number of samples of Precise Guided Missiles(PGMs) for test and evaluation are statistically problematic to make reasonable decisions thus use the budget efficiently. Also, the method to verify an accuracy rate of the PGMs using these old methods seems to be lack of objectiveness. This paper presents an effective, efficient solution adapted from the clinical medicine testing method of healthcare industry research, which may overcome our problems. This method considers and addresses both manufacturers' and consumers' risk simultaneously. By taking into account the weapon system project characteristics which take a relatively longer time and require higher-level budget, this approach also suggests a reasonable and feasible method to determine the amount of samples of the PGMs and making a criterion to verify an accuracy rate of the missiles that are required to test. Thus, this method is expected to contribute to acquisition and operations of high-reliability PGMs by MND and its field-users.